As of 2025-10-19, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.43 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.13 CAD, the upside of Newscope Capital Corporation is -419.26%.
Based on its market price of 0.13 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 419.26%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.43 - -0.43 | -0.43 | -419.26% |
| P/E | (0.01) - (0.11) | (0.01) | -108.3% |
| DDM - Stable | (0.31) - 3.38 | 1.54 | 1038.2% |
| DDM - Multi | (0.16) - 1.43 | (0.38) | -378.6% |
| Market Cap (mil) | 11.51 |
| Beta | 0.99 |
| Outstanding shares (mil) | 88.52 |
| Enterprise Value (mil) | 11.03 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.73% |
| Cost of Debt | 5.00% |
| WACC | 4.71% |